NAPLEX Quiz
20 questions · no time limit
0:00
MEDICATION USE PROCESS
Question 1 of 20
No time limit
Current
Answered
Flagged
Not seen
A 66-year-old man (weight 79 kg) with metastatic colorectal cancer is receiving bevacizumab (Avastin) plus chemotherapy. The oncology clinic plans to switch to bevacizumab-awwb (Mvasi). Current medications: bevacizumab as above, fluorouracil per protocol, dexamethasone premedication per protocol. What counseling point is crucial when switching to a biosimilar?
YOUR PROGRESS
20
QUESTIONS
Ready when you are
Answer in any order. Your progress shows here as you go.
QUESTIONS
KEYBOARD
Pick an answer ABCD
Next question ↵→
Previous ←
Flag for review F
Answers save as you go · flagged questions come back at the end